全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Malignant Meningioma: Two Cases Observed at the Hospital Center of Soavinandriana, Antananarivo

DOI: 10.4236/ojpathology.2023.132009, PP. 87-92

Keywords: Central Nervous System, Malignant Meningioma, WHO Grade III Meningioma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Meningiomas are tumors formed by arachnoid cells, typically attached to the inner surface of the dura mater. Malignant forms are rare and no case has been reported in the Malagasy literature. The objective of our study is to report two Malagasy cases of malignant meningioma and to discuss the epidemiological and anatomical-clinical particularities of this tumor. Observation: The first patient, a 41-year-old woman, presented with a rapidly progressive intracranial hypertension syndrome. The patient had undergone surgery two years earlier for a grade II meningioma and had no family history of meningioma, neurofibromatosis, or personal history of brain irradiation or head trauma. Her brain scan showed a heterogeneous polylobed left parieto-occipital mass with a meningeal implantation base. The anatomopathological examination of the samples revealed a malignant meningioma. The second patient was a 33-year-old man, operated for grade I meningioma eleven months before admission, with no other personal or family history. The patient was hospitalized for tumor recurrence with signs of intracranial hypertension. The brain computed tomography (CT) scan showed a heterogeneous extra-axial tumor in right temporo-parietal lobe. Surgical excision was performed. On histological examination, a proliferation of tumor cells of meningothelial appearance with papillary architecture was observed, leading to the diagnosis of malignant meningioma. Conclusion: Malignant meningioma is a rare and serious entity. The clinical manifestations are nonspecific and imaging may mimic a low-grade meningioma. The diagnosis of certainty is histological and is based on essentially morphological criteria. The latter condition the overall survival of the patient and the therapeutic conduct.

References

[1]  Louis, D.N., Ohgaki, H., Wiestler, O.D. and Canevee, W.K. (2007) WHO Classification of Tumours of the Central Nervous System. IARC, Lyon.
[2]  Patil, S., Scheithauer, B.W., Strom, R.G., et al. (2011) Malignant Meningiomas with Epithelial (Adenocarcinoma-Like) Metaplasia: A Study of 3 Cases. Neuro-Surgery, 69, 884-892.
https://doi.org/10.1227/NEU.0b013e318222dc6f
[3]  Perry, A., Scheithauer, B.W., Stafford, S.L., Lohse, C.M. and Wollan, P.C. (1999) “Malignancy” in Meningiomas: A Clinicopathologic Study of 116 Patients, with Grading Implications. Cancer, 85, 2046-2056.
https://doi.org/10.1002/(SICI)1097-0142(19990501)85:9%3C2046::AID-CNCR23%3E3.0.CO;2-M
[4]  Kshettry, V.R., Ostrom, Q.T., Kruchko, C., et al. (2015) Descriptive Epidemiology of World Health Organization Grades II and III Intracranial Meningiomas in the United States. Neuro-Oncology, 17, 1166-1173.
https://doi.org/10.1093/neuonc/nov069
[5]  Sadetzki, S., Flint-Richter, P., Starinsky, S., et al. (2005) Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas. Cancer Epidemiology, Biomarkers & Prevention, 14, 969-976.
https://doi.org/10.1158/1055-9965.EPI-04-0366
[6]  Shen, Y., Nunes, F., Stemmer-Rachamimov, A., et al. (2009) Genomic Profiling Distinguishes Familial Multiple and Sporadic Multiple Meningiomas. BMC Medical Genomics, 2, 42.
https://doi.org/10.1186/1755-8794-2-42
[7]  Claus, E.B., Black, P.M., Bondy, M.L., et al. (2007) Exogenous Hormone Use and Meningioma Risk: What Do We Tell Our Patients? Cancer, 110, 471-476.
https://doi.org/10.1002/cncr.22783
[8]  Barnett, G.H., Chou, S.M. and Bay, J.W. (1986) Posttraumatic Intracranial Meningioma: A Case Report and Review of the Literature. Neurosurgery, 18, 75-78.
https://doi.org/10.1227/00006123-198601000-00012
[9]  Pallud, J., Fontaine, D. and Duffau, H. (2010) Natural History of Incidental World Health Organization Grade II Gliomas. Annals of Neurology, 68, 727-733.
https://doi.org/10.1002/ana.22106
[10]  Yang, S.Y., Park, C.K., Park, S.H., et al. (2008) Atypical and Anaplastic Meningiomas: Prognostic Implications of Clinicopathological Features. Journal of Neurology, Neurosurgery and Psychiatry, 79, 574-580.
https://doi.org/10.1136/jnnp.2007.121582
[11]  Ding, D., Starke, R.M., Hantzmon, J., et al. (2013) The Role of Radiosurgery in the Management of WHO Grade II and III Intracranial Meningiomas. Neurosurgical Focus, 35, E16.
https://doi.org/10.3171/2013.9.FOCUS13364
[12]  Champeaux, C., Wilson, E., Brandner, S., et al. (2015) World Health Organization Grade III Meningiomas. A Retrospective Study for Outcome and Prognostic Factors Assessment. British Journal of Neurosurgery, 29, 693-698.
https://doi.org/10.3109/02688697.2015.1054350
[13]  McDermott, M.W. et al. (2003) Intraventricular Meningiomas. Neurosurgery Clinics of North America, 14, 559.
https://doi.org/10.1016/S1042-3680(03)00055-X
[14]  Kunimatsu, A., Kanimatsu, N., Kamiya, K., et al. (2016) Variants of Meningiomas: A Review of Imaging Findings and Clinical Features. Japanese Journal of Radiology, 34, 459-469.
https://doi.org/10.1007/s11604-016-0550-6
[15]  Jääskeläinen, J., Haltia, M. and Servo, A. (1986) Atypical and Anaplastic Meningiomas: Radiology, Surgery, Radiotherapy and Outcome. Surgical Neurology, 25, 233-242.
https://doi.org/10.1016/0090-3019(86)90233-8
[16]  Lim, Y.S., Kim, M.K., Park, B.J., et al. (2013) Long-Term Clinical Outcomes of Malignant Meningiomas. Brain Tumor Research and Treatment, 1, 85-90.
https://doi.org/10.14791/btrt.2013.1.2.85

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133